Triazolo and tetrazolo pyrimidine derivatives as HNE inhibitors for treating COPD
Abstract:
The present invention relates to novel heterocyclically fused diaryldihydropyrimidine derivatives, to processes for their preparation, to their use alone or in combination for the treatment and/or prevention of diseases and also to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of disorders of the lung and the cardiovascular system.
Information query
Patent Agency Ranking
0/0